Venturi Wealth Management LLC Purchases 574 Shares of STERIS plc (NYSE:STE)

Venturi Wealth Management LLC boosted its position in STERIS plc (NYSE:STE) by 45.4% in the third quarter, HoldingsChannel reports. The firm owned 1,837 shares of the medical equipment provider’s stock after buying an additional 574 shares during the quarter. Venturi Wealth Management LLC’s holdings in STERIS were worth $446,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in STE. West Coast Financial LLC boosted its stake in shares of STERIS by 2.8% during the third quarter. West Coast Financial LLC now owns 1,640 shares of the medical equipment provider’s stock valued at $398,000 after purchasing an additional 45 shares during the period. Taylor Frigon Capital Management LLC grew its stake in STERIS by 0.8% in the second quarter. Taylor Frigon Capital Management LLC now owns 6,175 shares of the medical equipment provider’s stock worth $1,356,000 after purchasing an additional 46 shares in the last quarter. J.Safra Asset Management Corp raised its position in STERIS by 77.9% during the 1st quarter. J.Safra Asset Management Corp now owns 121 shares of the medical equipment provider’s stock valued at $27,000 after purchasing an additional 53 shares in the last quarter. Mather Group LLC. raised its position in STERIS by 7.6% during the 2nd quarter. Mather Group LLC. now owns 763 shares of the medical equipment provider’s stock valued at $172,000 after purchasing an additional 54 shares in the last quarter. Finally, EverSource Wealth Advisors LLC grew its position in shares of STERIS by 16.5% during the 1st quarter. EverSource Wealth Advisors LLC now owns 402 shares of the medical equipment provider’s stock worth $82,000 after buying an additional 57 shares in the last quarter. Hedge funds and other institutional investors own 94.69% of the company’s stock.

Insider Buying and Selling at STERIS

In related news, CFO Michael J. Tokich sold 23,332 shares of the firm’s stock in a transaction dated Tuesday, September 10th. The stock was sold at an average price of $247.00, for a total transaction of $5,763,004.00. Following the completion of the sale, the chief financial officer now directly owns 42,930 shares of the company’s stock, valued at approximately $10,603,710. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 1.14% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms have commented on STE. KeyCorp raised their target price on shares of STERIS from $255.00 to $265.00 and gave the company an “overweight” rating in a research report on Tuesday, September 3rd. JMP Securities reaffirmed a “market outperform” rating and set a $265.00 price target on shares of STERIS in a research report on Wednesday, August 7th. StockNews.com lowered STERIS from a “strong-buy” rating to a “buy” rating in a report on Tuesday, October 29th. Stephens reissued an “overweight” rating and set a $260.00 target price on shares of STERIS in a research note on Thursday, November 7th. Finally, Needham & Company LLC reissued a “hold” rating on shares of STERIS in a research note on Friday, November 8th. Two research analysts have rated the stock with a hold rating and five have given a buy rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $253.00.

STERIS Price Performance

NYSE:STE opened at $222.73 on Wednesday. The stock has a 50 day moving average price of $231.90 and a 200 day moving average price of $228.11. The stock has a market cap of $21.96 billion, a PE ratio of 50.85 and a beta of 0.85. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.49 and a current ratio of 2.41. STERIS plc has a one year low of $195.47 and a one year high of $248.24.

STERIS (NYSE:STE) last posted its quarterly earnings results on Wednesday, November 6th. The medical equipment provider reported $2.14 EPS for the quarter, topping the consensus estimate of $2.12 by $0.02. The business had revenue of $1.33 billion for the quarter, compared to analyst estimates of $1.33 billion. STERIS had a return on equity of 13.78% and a net margin of 8.02%. The company’s quarterly revenue was up 7.3% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $2.03 EPS. Equities research analysts expect that STERIS plc will post 9.15 EPS for the current fiscal year.

STERIS Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, December 19th. Stockholders of record on Tuesday, November 19th will be paid a $0.57 dividend. The ex-dividend date is Tuesday, November 19th. This represents a $2.28 annualized dividend and a dividend yield of 1.02%. STERIS’s dividend payout ratio (DPR) is 52.05%.

STERIS Company Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.